Brian Michael Brown

CLO Brian Michael Brown sells 40,000 AVPT shares for $525,693.58 under pre-arranged 10b5-1 plan

Brian Michael Brown, Chief Legal Officer, executed two separate sales totaling 40,000 shares for $525,693.58 under a 10b5-1 trading plan adopted on 2025-12-16, reducing his holdings from 859.7K to 819.7K shares (-4.7%). The stock has appreciated +21.6% over the 30-day period and +31.4% over the 90-day period within its 52-week range of $8.84–$19.95, currently at $13.19. His prior sales at AVPT show mixed outcomes: five prior trades recorded 30-day returns of -1.2% to -7.4% and 90-day returns of -9.9% to -17.5%, though this transaction is scheduled under a pre-arranged plan rather than discretionary. The company's fundamentals show revenue of $117.2M, net income of $15.2M, annual revenue growth of +26.9%, and a P/E of 59.95.

Chief Legal Officer Brian Michael Brown sold 35,000 shares at blended avg $15.56 on 2025-09-23; stock down 23.9% from 52-week high.

Brown's 3 separate sales totaling 35,000 shares for $544,618.86 occurred as AVPT trades 23.9% below its 52-week high of $19.99, with 90-day returns of -20.8%. His prior trades at AVPT show 2 of 2 measurable 90-day outcomes were well-timed (negative returns after sale dates), though the latest two sales (2025-09-18 and 2025-08-25) have outcomes not yet measurable. He retains 633,741 shares post-transaction, representing a 5.2% reduction in holdings. The company's fundamentals show revenue growth of 21.6% year-over-year to $102,018,000 in the latest quarter, though full-year net income was negative despite recent quarterly profitability of $2,893,000. The timing of these sales into a declining stock price—coinciding with recent broader weakness—warrants observation of whether this pattern continues or reverses.

CLO Brown sold 500.0K shares (43.8% of holdings) at $15.21 on 2025-09-18; stock down 21.2% from 52-week high, company unprofitable FY.

Brian Michael Brown, Chief Legal Officer, sold 500,000 shares at $15.21, reducing his position from 1.14M to 640.3K shares (a 43.8% reduction). At the $15.75 current price, the trade was executed 3.5% above current levels but 21.2% below the 52-week high of $19.99. His prior AVPT sales show mixed timing outcomes: 2 of 3 measurable 90-day periods were well-timed (stock fell after sale), while 1 was poorly timed (stock rose 23.4% post-sale). The company reported $102.0M quarterly revenue with +21.6% annual growth, but remains unprofitable on a full-year basis. The magnitude of this sale—liquidating 43.8% of holdings in a single transaction—occurs against a backdrop of stock weakness (down 17.4% over 90 days) and persistent profitability challenges, distinguishing it from routine equity transactions.

Chief Legal Officer Brown sold 35,000 AVPT shares at $15.47 on 2025-08-25; stock now $15.80, down 14.0% in 30 days.

Brian Michael Brown, Chief Legal Officer, sold 35,000 shares (35.0K shares) at $15.47 on 2025-08-25, reducing his holdings from 1,190,443 shares to 1,155,443 shares. The transaction occurred as AVPT trades 21.0% below its 52-week high and has declined 14.0% over the past 30 days. Brown's cross-ticker track record shows prior sells were well-timed at a 33.33% rate with an average 90-day return of +7.4%, suggesting selective selling discipline; however, at AVPT specifically, his timing has been mixed—of 5 prior same-ticker sales, only 1 of 3 measurable at the 90-day horizon was well-timed. The company reported recent quarterly revenue of $102.0M with +21.6% annual growth, yet remains unprofitable on a full-year basis with net income of $2.9M in the latest quarter. This sale does not point to a clear conviction shift, but the continued downward price pressure and mixed prior timing at this ticker warrant monitoring of subsequent filings.

CLO Brown sold 35,000 AVPT shares at $18.74 on 2025-07-23; retains 1,190,443 shares post-sale

Chief Legal Officer Brian Michael Brown sold 35,000 shares (-2.9% of prior holdings) at $18.74, a price near but within the 52-week range of $9.70–$19.99. The stock is currently at $18.56, within 7.2% of its 52-week high. Brown's same-ticker history at AVPT shows mixed timing: his four prior sales included one notably well-timed sale on 2025-04-23 (which saw +20.6% 30-day and +23.4% 90-day returns, indicating he sold before strength) and three others with weaker or negative short-term outcomes, with 0 of 2 measurable 90-day outcomes showing sales before declines. The company posted recent quarterly revenue of $93.1M with net income of $3.6M, but remains unprofitable on an annual basis despite +21.6% annual revenue growth. This sale represents a modest reduction in a substantial 1.19M-share position, with no pattern clearly indicating predictive selling acumen at this ticker.

AVPT CLO Brian Michael Brown sold 35,000 shares at $18.23; retains 1.23M shares. Stock up 26.7% in 90 days; revenue growth strong at +21.6% but company unprofitable full-year.

Brown sold 35,000 shares (35.0K shares) of his 1.26M shares for $638.0K on 2025-06-23, reducing his stake by 2.8% while retaining substantial holdings of 1.23M shares. The sale occurred at $18.23, below the current price of $19.08 and 4.6% below the 52-week high, during a period of strong recent momentum (90-day return +26.7%, 30-day return +4.7%). His track record at AVPT shows mixed timing outcomes: two recent prior sales produced opposing outcomes (one +20.6% at 30 days, another -1.3% at 30 days), and his one measurable 90-day outcome at this ticker was well-timed (-2.0% at 30 days, +16.6% at 90 days). Fundamentals remain asymmetric—the company reported +21.6% annual revenue growth and $93.1M quarterly revenue, but was unprofitable on a full-year basis, limiting the strategic clarity of the sale relative to company trajectory. The modest reduction of a very large remaining position, combined with conflicting timing signals and underlying profitability uncertainty, suggests a routine portfolio action rather than a material signal.

CLO Brian Michael Brown sold 35,000 AVPT shares at $18.19 on 2025-05-23 for $636.6K; stock up 15.3% in 30 days.

Chief Legal Officer Brian Michael Brown sold 35,000 shares (35.0K shares) at $18.19 on 2025-05-23, reducing his holdings from 1.31M to 1.28M shares. The stock has risen 15.3% over the preceding 30 days and currently trades at $18.59, above the sale price. His prior two sales at AVPT showed mixed timing outcomes: the 2025-04-23 sale appreciated 20.6% in the following 30 days, while the 2025-03-24 sale declined 2.0% in the subsequent period. Across his broader cross-ticker track record, two prior sells averaged a 30-day return of +9.4%, suggesting sales have typically preceded continued gains. The company recently reported $93.1M in quarterly revenue with +21.6% annual growth, though it remains unprofitable on a full-year basis, which may warrant monitoring alongside executive equity flows.

Chief Legal Officer Brown Brian Michael sold 35,000 AVPT shares at $15.11 on 2025-04-23 (value $528,850.00)

Brian Michael Brown, Chief Legal Officer of AvePoint, sold 35,000 shares at $15.11, reducing his holdings from 1.35M to 1.31M shares (-2.6%). The transaction occurred when the stock was trading 18.8% below its 52-week high of $19.80, and the company had just delivered quarterly revenue of $88.8M with net income of $2.9M. While AvePoint demonstrates strong annual revenue growth of +21.6%, it was unprofitable over its most recent full fiscal year, creating a backdrop of solid operational momentum offset by profitability challenges. Brown's cross-ticker track record shows 1 prior sell with an average 30-day return of -2.0%; at AVPT specifically, his prior sell on 2025-03-24 has posted a -2.0% 30-day outcome, though the 90-day measurable history for same-ticker trades remains limited. The transaction size represents a modest reduction of his substantial remaining stake, occurring in a period when the stock has rallied 6.7% over 30 days despite declines over the longer 90-day window.

CLO Brian Michael Brown sells 35,000 AVPT shares at $15.40; still holds 1.35M shares post-sale

Chief Legal Officer Brian Michael Brown sold 35,000 shares (35.0K shares) at $15.40 on 2025-03-24, reducing his holdings by 2.5% to 1,347,145 shares (1.35M shares). The sale occurs at a price that is currently 1.1% above the present market price of $15.23, though the stock has declined 23.1% from its 52-week high of $19.80. AvePoint reported latest quarterly revenue of $88,804,000.00 ($88.8M) and 21.6% annual revenue growth, but the company was unprofitable over its most recent full fiscal year, creating a backdrop of revenue momentum contrasted against negative earnings. The sale is relatively modest in scale against Brown's large remaining position, with no indication of systematic or coordinated insider activity present in this filing.